Skip to main content
Log in

Simultaneous Quantification of Benazepril, Gliclazide and Valsartan in Human Plasma by LC–MS–MS and Application for Rapidly Measuring Protein Binding Interaction between Rhein and These Three Drugs

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

For new drug candidates with high protein binding in the treatment of diabetic nephropathy, their influence on the protein bindings of angiotensin-converting enzyme inhibitors, sulfonylurea drugs, and angiotensin receptor blockers should be predicted to prevent side effects. To provide an efficient tool for this study, a sensitive and rapid LC–MS–MS method was developed for the simultaneous quantification of representative drugs, benazepril, gliclazide and valsartan in human plasma. Chromatographic separation was performed on a Shim-pack VP-ODS C18 column (250 × 2.0 mm i.d., 5 μm) using methanol–0.05% formic acid (90:10, v/v) as mobile phase. Detection was performed on a triple quadrupole tandem mass spectrometer equipped with an electrospray ionization source and operated in SRM mode. Lower limits of quantification were 2, 2 and 20 ng−1 mL for benazepril, gliclazide and valsartan with 0.1 mL plasma sample. The method fulfills the precision, accuracy, linearity, sensitivity, selectivity requirements to quantify the three drugs and has been successfully used to studying protein binding of benazepril, gliclazide and valsartan in the presence of rhein.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Krentz AJ, Bailey CJ (2005) Drugs 65:385–411. doi:10.2165/00003495-200565030-00005

    Article  CAS  Google Scholar 

  2. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) N Engl J Med 329:1456–1462. doi:10.1056/NEJM199311113292004

    Article  CAS  Google Scholar 

  3. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I (2001) N Engl J Med 345:851–860. doi:10.1056/NEJMoa011303

    Article  CAS  Google Scholar 

  4. Brenner BM, Cooper ME, De Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S (2001) N Engl J Med 345:861–869. doi:10.1056/NEJMoa011161

    Article  CAS  Google Scholar 

  5. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M (1993) Ann Intern Med 118:577–581

    CAS  Google Scholar 

  6. Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P (2001) N Engl J Med 345:870–878. doi:10.1056/NEJMoa011489

    Article  CAS  Google Scholar 

  7. Dasgupta Clinica A (2007) Chim Acta 377:1–13. doi:10.1016/j.cca.2006.08.026

    Article  Google Scholar 

  8. Lang W (1988) Pharmacology 36(Suppl 1):158–171. doi:10.1159/000138436

    Article  CAS  Google Scholar 

  9. Choi SB, Ko BS, Park SK, Jang JS, Park S (2006) Life Sci 78(9):934–942. doi:10.1016/j.lfs.2005.05.101

    Article  CAS  Google Scholar 

  10. Tan L, Yuan YS, Yang JW, Qiu Q (1998) Bull Jinling Hosp 11(2):112–115

    Google Scholar 

  11. Guo XH, Liu ZH, Dai CS, Li H, Liu D, Li LS (2001) Acta Pharmacol Sin 22(10):934–938

    CAS  Google Scholar 

  12. Zhu J, Liu Z, Li Y (2001) Zhonghua Nei Ke Za Zhi 40(8):537–542

    CAS  Google Scholar 

  13. Leishi Li (2001) US patent, US 6,197,818, B1

  14. Ho ENM, Yiu KCH, Wan TSM, Stewart BD, Watkins KL (2004) J Chromatogr B Analyt Technol Biomed Life Sci 1:65–73

    Google Scholar 

  15. Maurer HH, Kratzsch C, Kraemer T, Peters FT, Weber AA (2002) J Chromatogr B Analyt Technol Biomed Life Sci 773:63–73. doi:10.1016/S1570-0232(01)00618-3

    Article  CAS  Google Scholar 

  16. Zhong GP, Bi HC, Zhou SF, Chen X, Huang M (2005) J Mass Spectrom 40:1462–1471. doi:10.1002/jms.907

    Article  CAS  Google Scholar 

  17. Koseki N, Kawashita H, Hara H, Niina M, Tanaka M, Kawai R, Nagae Y, Masuda N (2007) J Pharm Biomed Anal 43:1769–1772. doi:10.1016/j.jpba.2006.12.030

    Article  CAS  Google Scholar 

  18. Li H, Wang YW, Jiang Y, Tang YB, Wang J, Zhao LM, Gu JK (2007) J Chromatogr B Analyt Technol Biomed Life Sci 852:436–442. doi:10.1016/j.jchromb.2007.02.014

    Article  CAS  Google Scholar 

  19. Wang XD, Chan EL, Chen X, Liao XX, Tang C, Zhou ZW, Huang M, Zhou SF (2007) J Pharm Biomed Anal 44:224–230. doi:10.1016/j.jpba.2007.01.009

    Article  CAS  Google Scholar 

  20. Vonaparti A, Kazanis M, Panderi I (2006) J Mass Spectrom 41:593–605. doi:10.1002/jms.1014

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We greatly thank Professor Sun Fenzhi for kind assistance in the revision of the paper. This study was supported by National “863” Project (No. 2003AA2Z347A, 2005AA2Z3C70, 2002AA2Z3113).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guangji Wang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hu, X., Zheng, Y., Sun, J. et al. Simultaneous Quantification of Benazepril, Gliclazide and Valsartan in Human Plasma by LC–MS–MS and Application for Rapidly Measuring Protein Binding Interaction between Rhein and These Three Drugs. Chroma 69, 843–852 (2009). https://doi.org/10.1365/s10337-009-1017-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1365/s10337-009-1017-z

Keywords

Navigation